Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2025-12-25 @ 8:28 PM
Study NCT ID:
NCT06388369
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-29
First Post:
2024-04-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
Sponsor:
University Hospital, Essen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-19
First Submit QC Date:
None
Study First Post Date:
2024-04-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-24
Last Update Post Date:
2024-04-29
Last Update Post Date Type:
ACTUAL